USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program: Quarterly Report Fiscal Year 2020, Quarter 3 (April-June 2020)

The program is funded by the US Agency for International Development (USAID) and implemented by a team led by Management Sciences for Health (MSH). The MTaPS Program's goal is to help countries strengthen their pharmaceutical systems to ensure that pharmaceutical systems deal fairly with population subgroups differentiated by various parameters. The program's theory of change is based on USAID's Vision for Pharmaceutical Systems Strengthening, which posits six functions of health systems that must be strengthened to achieve sustained and equitable access to essential, high-quality services. These functions include human resources, health finance, health governance, health information, medical products/vaccines/technologies, and service delivery. The MTaPS Program has adopted this framework to the pharmaceutical sector, focusing on the following key areas: pharmaceutical-sector governance, institutional and human resource capacity, availability and use of pharmaceutical information, pharmaceutical-sector financing, pharmaceutical services, and pharmaceutical services financing. The MTaPS Program has made significant progress in strengthening pharmaceutical systems in various countries. In the Global Health Security Agenda, the program has supported countries in developing and implementing national action plans to prevent, detect, and respond to infectious disease threats. In the Maternal, Newborn, and Child Health portfolio, the program has worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The program has also made progress in the Office of Health Systems, Cross Bureau Funding portfolio, where it has supported countries in developing and implementing policies and guidelines to improve the quality and safety of pharmaceuticals. In the Gender Activities portfolio, the program has worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products for women and girls. The MTaPS Program has also made progress in the Cross-Cut Activities portfolio, where it has supported countries in developing and implementing policies and guidelines to improve the quality and safety of pharmaceuticals. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products for vulnerable populations. The program has also made progress in the Progress Toward Objectives portfolio, where it has supported countries in achieving the following objectives: pharmaceutical-sector governance, institutional and human resource capacity, availability and use of pharmaceutical information, pharmaceutical-sector financing, pharmaceutical services, and pharmaceutical services financing. The program has also made progress in the Progress by Regional Bureau Portfolio, where it has supported countries in the Asia Regional Bureau, Intergovernmental Authority on Development (IGAD) and East African Community (EAC) portfolios. The program has also made progress in the Progress by Country portfolio, where it has supported countries in Bangladesh, Burkina Faso, Cameroon, Côte d'Ivoire, Democratic Republic of Congo, Ethiopia, Kenya, Mali, Mozambique, Nepal, Philippines, Rwanda, Senegal, Tanzania, Uganda, and other countries. The program has worked with these countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The MTaPS Program has also made progress in the Monitoring, Evaluation, and Learning portfolio, where it has supported countries in developing and implementing monitoring and evaluation frameworks to track progress toward the program's objectives. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The program has also made progress in the Annex 1. MTAPS Indicator Tracking Table, where it has tracked progress toward the program's objectives. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The MTaPS Program has also made progress in the Pharmaceutical Management Information System (PMIS) portfolio, where it has supported countries in developing and implementing PMIS to track pharmaceutical stock levels, track inventory, and track patient data. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The program has also made progress in the Supply Chain Management Portal (SCMP) portfolio, where it has supported countries in developing and implementing SCMP to track pharmaceutical stock levels, track inventory, and track patient data. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The MTaPS Program has also made progress in the Systems for Improved Access to Pharmaceuticals and Services (SIAAPS) portfolio, where it has supported countries in developing and implementing SIAAPS to track pharmaceutical stock levels, track inventory, and track patient data. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines and health products. The program has also made progress in the Reproductive Health Supplies Coalition (RHSC) portfolio, where it has supported countries in developing and implementing RHSC to track pharmaceutical stock levels, track inventory, and track patient data. The program has also worked with countries to strengthen their pharmaceutical systems to improve access to essential medicines